Neuropsychiatric Immune-Related Adverse Events Induced by Pembrolizumab in a Patient With Lung Adenocarcinoma and Systemic Lupus Erythematosus
Internal Medicine - Japan
doi 10.2169/internalmedicine.3782-19
Full Text
Open PDFAbstract
Available in full text
Date
February 15, 2020
Authors
Publisher
Japanese Society of Internal Medicine